TScan Therapeutics (TCRX) Net Margin Growth (1y) (2021 - 2026)
TScan Therapeutics (TCRX) Net Margin Growth (1y) (2021 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | 1,491.00 |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | 1,120.00 |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | -653.00 |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | 447.00 |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | - |
| 10 | TScan Therapeutics | 100.59 Mn | -27.47 Mn | - | -121,560.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -121,560.00 |
| Dec 31, 2025 | 577,368.00 |
| Sep 30, 2025 | 142,695.00 |
| Jun 30, 2025 | 470,560.00 |
| Mar 31, 2025 | 362,189.00 |
| Dec 31, 2024 | -667,730.00 |
| Sep 30, 2024 | -225,746.00 |
| Jun 30, 2024 | -514,308.00 |
| Mar 31, 2024 | -493,642.00 |
| Dec 31, 2023 | 28,135.00 |
| Sep 30, 2023 | -10,859.00 |
| Jun 30, 2023 | -39,160.00 |
| Mar 31, 2023 | 14,577.00 |
| Dec 31, 2022 | -5,974.00 |
| Sep 30, 2022 | 56,550.00 |
| Jun 30, 2022 | 78,330.00 |
| Mar 31, 2022 | -14,446.00 |
| Dec 31, 2021 | 88,805.00 |
| Sep 30, 2021 | 142,386.00 |